Rob Wojciechowski Joins ELIQUENT Life Sciences

ELIQUENT Life Sciences (ELIQUENT) has appointed Rob Wojciechowski as managing director of the Consulting Practice across Europe and the Asia-Pacific region.

“Rob’s appointment comes at a pivotal moment for ELIQUENT. His extensive experience in managing consulting practices across diverse markets will be instrumental in expanding our footprint and enhancing our service offerings to meet the unique needs of clients in Europe and the APAC region,” ELIQUENT Life Sciences CEO Tim Dietlin said.

A seasoned life sciences executive and NED board member, Wojciechowski brings an extensive background in leadership, strategic consulting, and regional business growth. His expertise in operational delivery, building consulting practices and fostering client relationships aligns with ELIQUENT’s commitment to delivering innovative solutions to meet clients’ evolving needs. In his role at ELIQUENT, Wojciechowski will oversee the delivery and expansion of the firm’s consulting services.

Wojciechowski served for more than six years as senior vice president at Syneos Health (Previously INC Research/inVentiv Health), a biopharmaceutical solutions organization that provides integrated services across the entire product lifecycle, from clinical trials to commercialization.

Wojciechowski also has more than 20 years of senior leadership experience, including two years as a non-executive director at Sharpview Ophthalmology and key positions at INC Research, Kendle, PPD, and GSK. His roles have been focused on innovation, operational delivery and advancing global R&D in the pharmaceutical, biotechnology, and medical device sectors.

In his position at ELIQUENT, Wojciechowski will help build and grow the firm’s full-service solutions and integrated service offerings including regulatory affairs solutions, pharmacovigilance and post-market surveillance solutions, and quality and compliance solutions.

ELIQUENT Life Sciences is the fusion of six global regulatory consultancies: Validant, Greenleaf Health, DataRevive, Oriel Stat-a-Matrix, RApport Global, and IDEC. ELIQUENT team works cross-functionally to deliver the global solutions that pharmaceutical, biotechnology, and medical device companies need to gain and maintain authorization for the products. ELIQUENT’s services support innovators across therapeutic modalities, phase-based pathways, and major global markets. The firm’s growth is supported by GHO Capital, the European specialist investor in healthcare.